0001209191-20-035119.txt : 20200608
0001209191-20-035119.hdr.sgml : 20200608
20200608190853
ACCESSION NUMBER: 0001209191-20-035119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200605
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOMSICEK MICHAEL JOHN
CENTRAL INDEX KEY: 0001570392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 20950487
MAIL ADDRESS:
STREET 1: 28 OVERLOOK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-05
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001570392
TOMSICEK MICHAEL JOHN
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
1
0
0
0
Stock Option (right to buy)
3.74
2020-06-05
4
A
0
15000
0.00
A
2030-06-05
Common Shares
15000
15000
D
The shares subject to this option shall vest in equal monthly installments over the 12 months commencing July 5, 2020, provided that the shares subject to this option shall vest in full on the date of Issuer's 2021 annual meeting of shareholders, subject to recipient continuing to provide service to the Issuer through such vesting date.
/s/ Eric Popp, Attorney-in-Fact
2020-06-08